| Product Code: ETC7659929 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Prader-Willi Syndrome Drug Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Prader-Willi Syndrome Drug Market - Industry Life Cycle |
3.4 Israel Prader-Willi Syndrome Drug Market - Porter's Five Forces |
3.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Branded Drugs, 2021 & 2031F |
3.7 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.8 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.10 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 Israel Prader-Willi Syndrome Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Prader-Willi Syndrome Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about Prader-Willi Syndrome (PWS) in Israel |
4.2.2 Rising prevalence of PWS cases in Israel |
4.2.3 Government initiatives and policies supporting rare disease treatment development |
4.3 Market Restraints |
4.3.1 High cost of drug development and treatment for PWS |
4.3.2 Limited access to specialized healthcare facilities for PWS patients in Israel |
4.3.3 Stringent regulatory requirements for drug approval in Israel |
5 Israel Prader-Willi Syndrome Drug Market Trends |
6 Israel Prader-Willi Syndrome Drug Market, By Types |
6.1 Israel Prader-Willi Syndrome Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Paternal Deletion, 2021- 2031F |
6.1.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Maternal Uniparental Disomy (UPD), 2021- 2031F |
6.1.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Imprinting Defect, 2021- 2031F |
6.2 Israel Prader-Willi Syndrome Drug Market, By Branded Drugs |
6.2.1 Overview and Analysis |
6.2.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Genotropin, 2021- 2031F |
6.2.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Omnitrope Norditropin, 2021- 2031F |
6.2.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Prader-Willi Syndrome Drug Market, By Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.3.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Genetic Testing, 2021- 2031F |
6.3.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.4 Israel Prader-Willi Syndrome Drug Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.4.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Physical therapy, 2021- 2031F |
6.4.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Behavioral Therapy, 2021- 2031F |
6.5 Israel Prader-Willi Syndrome Drug Market, By Treatment |
6.5.1 Overview and Analysis |
6.5.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Medications, 2021- 2031F |
6.5.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Dietary treatment, 2021- 2031F |
6.5.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Human Growth Hormone replacement, 2021- 2031F |
6.5.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Sex hormone Replacement, 2021- 2031F |
6.6 Israel Prader-Willi Syndrome Drug Market, By Route of Administration |
6.6.1 Overview and Analysis |
6.6.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.6.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.6.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Intranasal, 2021- 2031F |
6.6.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Israel Prader-Willi Syndrome Drug Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Direct, 2021- 2031F |
6.7.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.7.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.8 Israel Prader-Willi Syndrome Drug Market, By End-Users |
6.8.1 Overview and Analysis |
6.8.2 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.8.3 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.8.4 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 Israel Prader-Willi Syndrome Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Prader-Willi Syndrome Drug Market Import-Export Trade Statistics |
7.1 Israel Prader-Willi Syndrome Drug Market Export to Major Countries |
7.2 Israel Prader-Willi Syndrome Drug Market Imports from Major Countries |
8 Israel Prader-Willi Syndrome Drug Market Key Performance Indicators |
8.1 Number of clinical trials conducted for PWS drugs in Israel |
8.2 Percentage of healthcare professionals trained in PWS treatment |
8.3 Patient adherence rate to prescribed PWS treatments |
9 Israel Prader-Willi Syndrome Drug Market - Opportunity Assessment |
9.1 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Branded Drugs, 2021 & 2031F |
9.3 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.4 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.6 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.7 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.7 Israel Prader-Willi Syndrome Drug Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Israel Prader-Willi Syndrome Drug Market - Competitive Landscape |
10.1 Israel Prader-Willi Syndrome Drug Market Revenue Share, By Companies, 2024 |
10.2 Israel Prader-Willi Syndrome Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here